KYMR Kymera Therapeutics

Watchlist

Close Apr 26 16:00 ET

2.05BMarket Cap-13242P/E (TTM)

Kymera Therapeutics Stock Analyst Ratings & Price Target

Updated: Apr 22, 2024

Based on 13 analysts giving stock ratings to Kymera Therapeutics in the past 3 months

Buy

Updated: Apr 22, 2024

The average Kymera Therapeutics stock price target is 44.00 with a max estimate of 56.00 and a min estimate of 30.00

Review Kymera Therapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 22, 2024

Buy

Updated: Apr 22, 2024

Overall